Premium
The Price of Success: Cost‐Effectiveness of Molecularly Targeted Agents
Author(s) -
Sleijfer S,
Verweij J
Publication year - 2009
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2008.245
Subject(s) - pharmacology , medicine
The advent of molecularly targeted agents has brought major breakthroughs in oncology. However, because these drugs are expensive and financial resources are limited, attention to their cost‐effectiveness is rapidly increasing. It seems that establishment of cost‐effectiveness is complex but is determined for the most part by the cost of drug acquisition and the drug's efficacy. This article examines the cost‐effectiveness of molecularly targeted drugs. Clinical Pharmacology & Therapeutics (2009); 85 , 2, 136–138 doi: 10.1038/clpt.2008.245